The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundation

Area of Science:

• Gynecologic Oncology
• Clinical Research
• Cancer Therapeutics

Background:

• The GOG Foundation, Inc. (GOG-F) is a non-profit organization dedicated to advancing research in gynecologic malignancies.
• GOG Partners (GOG-P) operates under GOG-F, distinct from federally funded NCI NRG Oncology.
• GOG-P functions as a Site Management Organization (SMO) to bolster clinical trial infrastructure.

Purpose of the Study:

• To detail the history and organizational structure of GOG Partners (GOG-P).
• To highlight GOG-P's role in expanding the US gynecologic oncology clinical trials infrastructure.
• To outline supportive programs within GOG-F that aid GOG-P's research endeavors.

Main Methods:

• Historical review of GOG-P's establishment and evolution.
• Description of GOG-P's operational model as an SMO.
• Summary of GOG-F's supporting programs for clinical research.

Main Results:

• GOG-P has a proven record of conducting high-quality clinical trials.
• GOG-P contributes to the development of novel FDA-approved treatments for gynecologic cancers.
• The SMO model enhances patient accrual, mentorship, and site support.

Conclusions:

• GOG-P significantly contributes to transformative gynecologic cancer research.
• The organizational structure supports a robust clinical trials infrastructure.
• GOG-P plays a vital role in advancing gynecologic oncology through dedicated research efforts.